Otsuka Holdings
4578.T
#663
Rank
NZ$63.85 B
Marketcap
NZ$121.09
Share price
-1.58%
Change (1 day)
41.24%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

Earnings for Otsuka Holdings (4578.T)

Earnings in 2023: NZ$1.78 Billion

According to Otsuka Holdings 's latest financial reports the company's current earnings are NZ$14.47 Billion. In 2023 the company made an earning of NZ$1.78 Billion a decrease over its 2022 earnings that were of NZ$2.25 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Otsuka Holdings from 2010 to 2023

Annual earnings

Year Earnings Change
2023NZ$1.78 B-20.93%
2022NZ$2.25 B-12.7%
2021NZ$2.58 B-19.92%
2020NZ$3.22 B13.9%
2019NZ$2.82 B52.07%
2018NZ$1.86 B11.22%
2017NZ$1.67 B-36.03%
2016NZ$2.61 B31.15%
2015NZ$1.99 B
2013NZ$4.13 B33.52%
2012NZ$3.10 B-4.65%
2011NZ$3.25 B45.53%
2010NZ$2.23 B